Editorial · 2026 · Open access

Beyond the label: patient-reported outcomes and post-approval communication in oncology

Jens Lehmann

BMJ Oncology, 5(1), e001082 · Published 1 January 2026 · DOI 10.1136/bmjonc-2026-001082

Open PDFView at the publisherCite this paper

In brief

“Beyond the label: patient-reported outcomes and post-approval communication in oncology” is an 2026 editorial by Jens Lehmann, published in BMJ Oncology. OpenAlex counts 1 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at BMJ Oncology.

Citations
1
Most cited in
2026 (1)
References
5
Authors
1

Abstract

Cancer clinical trials form the foundation for the approval and use of new anticancer therapies. Alongside traditional endpoints such as survival and tumour response, patient-reported outcomes (PROs) are now a cornerstone of oncology trials and are increasingly expected by regulators.1 By capturing symptoms and functional health directly from patients, PROs provide essential information for patient-focused drug development and shared decision-making.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lehmann, J. (2026). Beyond the label: patient-reported outcomes and post-approval communication in oncology. BMJ Oncology, 5(1), e001082. https://doi.org/10.1136/bmjonc-2026-001082

MLA 9

Lehmann, Jens. “Beyond the label: patient-reported outcomes and post-approval communication in oncology.” BMJ Oncology, vol. 5, no. 1, 2026, p. e001082. https://doi.org/10.1136/bmjonc-2026-001082.

Chicago

Lehmann, Jens. 2026. “Beyond the label: patient-reported outcomes and post-approval communication in oncology.” BMJ Oncology 5 (1): e001082. https://doi.org/10.1136/bmjonc-2026-001082.

Harvard

Lehmann, J. (2026) ‘Beyond the label: patient-reported outcomes and post-approval communication in oncology’, BMJ Oncology, 5(1), p. e001082. doi:10.1136/bmjonc-2026-001082.

IEEE

J. Lehmann, “Beyond the label: patient-reported outcomes and post-approval communication in oncology,” BMJ Oncology, vol. 5, no. 1, p. e001082, 2026, doi: 10.1136/bmjonc-2026-001082.

BibTeX

@article{lehmann2026beyond,
  title     = {{Beyond the label: patient-reported outcomes and post-approval communication in oncology}},
  author    = {Lehmann, Jens},
  journal   = {BMJ Oncology},
  year      = {2026},
  volume    = {5},
  number    = {1},
  pages     = {e001082},
  doi       = {10.1136/bmjonc-2026-001082},
  url       = {https://doi.org/10.1136/bmjonc-2026-001082}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • patient-reported outcomes
  • cancer clinical trials
  • cancer therapy
  • regulatory expectations
  • patient-focused drug development
  • shared decision-making
  • cancer symptoms
  • functional health

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Lehmann, J. (2026). Beyond the label: patient-reported outcomes and post-approval communication in oncology. BMJ Oncology, 5(1), e001082. https://doi.org/10.1136/bmjonc-2026-001082

How many times has this paper been cited?

1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at BMJ Oncology: sign in and open the PDF from this page.

Who wrote this paper?

Jens Lehmann.

What is the DOI of this paper?

10.1136/bmjonc-2026-001082, permanently at https://doi.org/10.1136/bmjonc-2026-001082. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.